DailyDoctor Archive Specialties Get app
Back to the 16 September 2026 edition

Research · 04 of 07

Parenteral steroids in early RA were linked to half the rate of ongoing steroid use at a year

When bridging early RA, prefer a parenteral glucocorticoid or set a firm oral taper, because oral courses were far more likely to persist.

Design
Prospective inception cohort analysis, adjusted logistic regression
Population
2,222 adults with early RA in the Canadian Early Arthritis Cohort
Primary outcome
Glucocorticoid use and advanced therapy escalation at 12 months
Effect
Steroid use at 1 year 47% (oral) vs 26% (parenteral); OR 9.8 vs 4.1 against no GC

This analysis of the Canadian Early Arthritis Cohort included 2,222 adults with newly diagnosed rheumatoid arthritis enrolled 2007-2023. In the first three months, 75% received no glucocorticoid, 19% oral, 5% parenteral (intra-articular or intramuscular) and 1% both.

At 12 months, glucocorticoid use was 8% without early steroids, 47% after oral, 26% after parenteral and 63% after both. Compared with no early steroid, the adjusted odds of steroid use at a year were 9.8 for oral and 4.1 for parenteral. Escalation to advanced therapy was similar (14% in both the oral and parenteral groups).

Bridging steroids in early RA are meant to be temporary, but oral courses often persist. A depot or intra-articular injection ends by design.

This is observational, and patients chosen for oral steroids may have had more widespread disease.

  • Consider intramuscular or intra-articular glucocorticoid as the bridge when starting csDMARDs.
  • If oral steroids are used, set a written tapering plan and stop date at the start.
  • Review steroid use at every visit in the first year.
  • Escalate DMARD therapy rather than prolonging steroids.

Why it matters

The route of a bridging steroid appears to decide whether it remains a bridge.

Don't overread it

This was observational; patients given oral steroids may have had different disease, so route may not be the cause of persistence.

The statistics, in plain English

Odds ratios of 9.8 and 4.1 compare each route with no steroids at all. The direct comparison, 47% vs 26% still on steroids, is the practical figure.

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

vasculitisraosteoporosisrheum

Tomorrow morning, before your first patient

One edition a day for rheumatology, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free
Daily Doctor All 27 specialties, every morning. Free.
Get the app